Treatment for drug allergies in paediatrics

Reading File

Finding Sources

Searching PubMed

"drug allergy" AND "children" AND "management"

Finding Sources

Reading File

Finding Sources

Searching PubMed

"drug hypersensitivity" AND "pediatric" AND "desensitization"

Reading File

Searching the Web

drug allergy management paediatrics children guidelines 2024 treatment desensitization

Reading File

I now have enough comprehensive content from all major sources to provide a thorough, well-structured answer. Let me compile the full response.

Treatment of Drug Allergies in Paediatrics

Drug hypersensitivity reactions in children are a significant clinical challenge. About 80% of adverse drug reactions are predictable and dose-dependent; the remaining 20% are unpredictable and include true allergic and immune-mediated reactions. Importantly, while up to 20% of patients report a drug allergy, confirmed allergy is present in under 1% - making accurate evaluation and de-labeling a core part of management.

1. Classification of Reactions (Relevant to Treatment Choice)

Understanding the reaction type guides treatment:

Type	Timing	Mechanism	Examples
Type I (Immediate)	Within 1-6 h	IgE-mediated (or IgE-independent via MRGPRX2)	Urticaria, angioedema, anaphylaxis
Type II	Delayed	Antibody-mediated cytotoxicity	Drug-induced hemolytic anaemia
Type III	Delayed	Immune complex-mediated	Serum sickness
Type IV (Delayed)	6 h to days/weeks	T-cell mediated	Maculopapular rash, DRESS, SJS/TEN, AGEP

Severity grading: mild = one organ (Grade 1); moderate = two or more organs (Grade 2); severe = vital sign changes (Grade 3). - Harrison's Principles of Internal Medicine, 22E

2. Immediate Management: Anaphylaxis

Anaphylaxis is the most urgent drug allergic emergency. The primary treatment is the same in children as adults, with weight-based dosing:

Epinephrine (first-line, non-negotiable):

IM epinephrine 0.01 mg/kg (up to 0.3 mg) into the anterolateral thigh
Use EpiPen Jr (0.15 mg) for children <30 kg; EpiPen (0.3 mg) for children ≥30 kg
Repeat every 5-15 minutes if no response

Epinephrine reverses bronchospasm and hypotension by opposing histamine: it relaxes bronchiolar smooth muscle and contracts vascular smooth muscle. - Katzung's Basic and Clinical Pharmacology, 16th Edition

Supportive measures:

Aggressive IV crystalloid fluid resuscitation
Supplemental oxygen; airway management (prone to obstruction in children)
Lay supine with legs elevated (or sitting up if respiratory distress)
IV/IM antihistamines (H1 blocker - diphenhydramine; H2 blocker - ranitidine/famotidine) - adjunct only, NOT a substitute for epinephrine
IV/oral corticosteroids (prednisolone 1-2 mg/kg) to reduce biphasic reactions
Bronchodilators (salbutamol/albuterol) for bronchospasm
Children <16 years who have anaphylaxis should be admitted under a paediatric medical team for monitoring - Leicestershire NHS Anaphylaxis & Drug Allergy Policy (updated 2024)

3. Acute Management of Non-Anaphylactic Drug Reactions

For mild-moderate skin reactions (urticaria, angioedema):

Stop the offending drug
Oral antihistamines (cetirizine, loratadine - preferred in children for non-sedating profile)
Short course of corticosteroids for significant angioedema

Corticosteroids (prednisone/prednisolone): Act via multiple mechanisms - immunosuppression (blocking IgE-producing B-cell clones, inhibiting IL-4 from Th2 cells), reduction of tissue inflammation and edema, and facilitation of catecholamine action in cells refractory to epinephrine. - Katzung's Basic and Clinical Pharmacology, 16th Edition

For delayed reactions / maculopapular rash:

Drug withdrawal is the primary step
Oral antihistamines + topical corticosteroids for pruritus
Systemic steroids if widespread or progressing
Contraindication to rechallenge if SCARS suspected (SJS/TEN, DRESS, AGEP) - even minute amounts of drug can trigger severe reactions

4. Severe Cutaneous Adverse Reactions (SCARs) in Children

SCARs - Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), DRESS, AGEP - require:

Immediate drug withdrawal
Admission to a burns/paediatric ICU for SJS/TEN
Supportive care: wound care, fluid/electrolyte management, nutritional support, ophthalmology review
Systemic immunosuppression is controversial in SJS/TEN; IVIG, cyclosporine, or anti-TNF agents (etanercept) used in some centres
DRESS: systemic corticosteroids, monitor for multi-organ involvement (liver, kidney, haematological)
Desensitization is absolutely contraindicated in SCARs - Harrison's Principles, 22E

5. De-labeling: Oral Drug Challenge

A key pillar of paediatric drug allergy management is de-labeling - removing an incorrect allergy label:

Single-dose oral challenges have been shown to be safe in children at low risk for penicillin allergy
Most children with suspected beta-lactam allergy (especially amoxicillin rash) are not truly allergic; many rashes are viral (e.g., amoxicillin rash in EBV/mononucleosis is not a true drug allergy)
Recent guidelines (WAO 2025, EAACI) increasingly favour direct oral provocation challenge without prior skin testing in low-risk paediatric patients
US Drug Allergy Registry (2025) provides practical recommendations for standardising antibiotic allergy testing in children
De-labeling has major downstream benefits: access to first-line antibiotics, reduced costs, better antimicrobial stewardship - WAO Statement 2025 [PMID: 40933958]

Diagnostic approach before oral challenge:

Skin prick test (SPT) / intradermal test - for IgE-mediated reactions (positive = wheal and flare within 10-15 min); note: may be false-negative if child is on antihistamines or steroids
Basophil activation test (BAT) - safer in vitro alternative for highly sensitized children
Serum-specific IgE - low sensitivity, useful mainly for penicillin and platinum compounds
Patch testing - for delayed type IV reactions (beta-lactams, anticonvulsants)

6. Drug Desensitization in Children

When the offending drug is indispensable (e.g., penicillin for neurosyphilis, cisplatin in oncology, co-trimoxazole in immunocompromised children), desensitization can safely restore tolerance:

Principle: Rapid multi-step delivery of sequential small doses (often starting at 1/100 or 1/1000 of target dose) recruits inhibitory mast cell/basophil phosphatase pathways, blocking IgE receptor signal transduction and mediator release. The desensitized state is temporary and must be repeated with each new course. - Harrison's Principles, 22E

Standard protocol (3-bag, 12-step):

Bags at 1/100, 1/10, and undiluted concentrations
Doubling doses every 15 minutes
Target dose reached in approximately 5.7 hours
4-bag protocols (starting at 1/1000) used for children with severe initial reactions

Indications in paediatrics (per Cernadas et al. 2023 [PMID: 37366205]):

Penicillin/beta-lactam allergy when alternatives are inadequate (cystic fibrosis, spina bifida patients with multiple antibiotic exposures)
Chemotherapy agents (platinums, taxanes) in paediatric oncology
Biologics (monoclonal antibodies) - hypersensitivity reactions reviewed in children by de Las Vecillas et al. 2023 [PMID: 36314361]
Sulfonamides in HIV/immunocompromised children
CFTR modulator drugs in cystic fibrosis

Contraindications to desensitization:

SCARs (SJS/TEN, DRESS, AGEP)
Type II (cytotoxic), Type III (serum sickness/vasculitis)
Single-organ toxic reactions

Adjuncts:

Omalizumab (anti-IgE) used as adjuvant pre-treatment in highly sensitized children with severe IgE-mediated reactions to reduce risk during desensitization
Premedication with antihistamines and corticosteroids tailored to initial symptom phenotype (steroids do not protect against anaphylaxis during desensitization)

7. Special Paediatric Considerations

Drug Class	Key Paediatric Notes
Penicillins / beta-lactams	Most common reported allergy; >90% of labelled children are not truly allergic; direct oral challenge is safe in low-risk children
Macrolides	True allergy uncommon; cross-reactivity infrequent; direct challenge preferred in non-severe reactions (2026 review)
NSAIDs/aspirin	COX-1 inhibition mechanism; aspirin desensitization used for polyp/asthma control in older children
Chemotherapy	Children with malignancies increasingly treated with desensitization protocols when platinum/taxane allergy develops
Biologics	Increasing use in paediatric IBD, rheumatology, oncology; protocol desensitization available
Anticonvulsants	High risk of DRESS/SJS (carbamazepine, lamotrigine); HLA genotyping may inform risk - Goldman-Cecil Medicine
Vancomycin	"Red Man Syndrome" - IgE-independent (MRGPRX2-mediated); slowing infusion rate + premedication is primary management
Cystic fibrosis	Repeated antibiotic exposures drive high sensitization rates; structured desensitization protocols well-established

8. Long-term / Preventive Management

All children with a history of drug-induced anaphylaxis should be prescribed and trained in self-injection of epinephrine autoinjectors
Consider medical alert identification (MedicAlert bracelet)
Refer to paediatric allergist/immunologist for formal allergy workup, skin testing, and supervised challenge
Maintain accurate allergy documentation with full reaction description (type, timing, severity) - mislabeling as "allergy" when the reaction was intolerance or viral exanthem causes significant harm

Key Recent Evidence

WAO Statement on drug hypersensitivity reactions in children (2025) - PMID: 40933958 - comprehensive current guidance
Cernadas J et al. "Desensitization in children allergic to drugs: indications, protocols, and limits." Pediatr Allergy Immunol 2023 [PMID: 37366205]
de Las Vecillas L et al. "Hypersensitivity reactions to biologics in children." Expert Opin Biol Ther 2023 [PMID: 36314361]

Summary: Treatment of drug allergy in paediatrics follows a stepwise approach - immediate epinephrine for anaphylaxis, drug withdrawal and symptomatic care for non-anaphylactic reactions, de-labeling via oral challenge in low-risk cases, and desensitization when the offending drug is indispensable. SCARs require specialist inpatient management and are a contraindication to desensitization. Long-term management includes epinephrine autoinjector prescription and allergist referral.

This is a shared conversation. Sign in to Orris to start your own chat.